ID

35558

Beschreibung

Eliminate Coronary Artery Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02245087

Link

https://clinicaltrials.gov/show/NCT02245087

Stichworte

  1. 08.03.19 08.03.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

8. März 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Coronary Artery Disease NCT02245087

Eligibility Coronary Artery Disease NCT02245087

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
men 35-50 years of age
Beschreibung

Gender | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
women 45 - 59 years of age (must be sterile or >2 years postmenopausal)
Beschreibung

Gender | Age | Female Sterilization | Postmenopausal state

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0015787
UMLS CUI [4]
C0232970
ldl cholesterol greater than 1.8 mmol/l (70 mg/dl) based on testing performed within 1 year
Beschreibung

Serum LDL cholesterol measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0428474
one risk factor for coronary heart disease other than lipid abnormality:
Beschreibung

Risk factor Quantity Coronary heart disease | Exception Lipid abnormality

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0035648
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0010068
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0549634
hypertension [bp >140 mmhg systolic]
Beschreibung

Hypertensive disease | Systolic Pressure

Datentyp

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0871470
family history of premature myocardial infarction [<60 years]
Beschreibung

Family history Myocardial Infarction Early

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0241889
UMLS CUI [1,2]
C0027051
UMLS CUI [1,3]
C1279919
south asian ethnic history
Beschreibung

South Asian

Datentyp

boolean

Alias
UMLS CUI [1]
C1519427
currently smoking
Beschreibung

Tobacco use

Datentyp

boolean

Alias
UMLS CUI [1]
C0543414
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
currently taking cholesterol lowering medication
Beschreibung

Anticholesteremic Agents

Datentyp

boolean

Alias
UMLS CUI [1]
C0003277
qualify for cholesterol lowering medication based on current guidelines
Beschreibung

Qualification Anticholesteremic Agents

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1709790
UMLS CUI [1,2]
C0003277
significant renal dysfunction (creatinine clearance <30 ml/min)
Beschreibung

Renal dysfunction | Creatinine clearance measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C3279454
UMLS CUI [2]
C0373595
significant hepatic dysfunction (ast/alt >2.0 times upper limit of normal)
Beschreibung

Liver Dysfunction | Aspartate aminotransferase increased | Alanine aminotransferase increased

Datentyp

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C0151904
UMLS CUI [3]
C0151905
active malignancy
Beschreibung

Malignant Neoplasms

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
diabetes
Beschreibung

Diabetes Mellitus

Datentyp

boolean

Alias
UMLS CUI [1]
C0011849
progressive or terminal illness, or other condition in which subject is unlikely to survive the study period
Beschreibung

Progressive Disease | Terminal illness | Condition Survival aspects Completion of clinical trial Unlikely

Datentyp

boolean

Alias
UMLS CUI [1]
C1335499
UMLS CUI [2]
C0679247
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C0220921
UMLS CUI [3,3]
C2732579
UMLS CUI [3,4]
C0750558
known allergy, hypersensitivity (anaphylaxis) ar adverse reaction to any statin
Beschreibung

Statin allergy | Anaphylaxis Statins | Adverse reactions Statins

Datentyp

boolean

Alias
UMLS CUI [1]
C0571873
UMLS CUI [2,1]
C0002792
UMLS CUI [2,2]
C0360714
UMLS CUI [3,1]
C0559546
UMLS CUI [3,2]
C0360714
participation in a clinical trial (except observational studies) within previous 30 days
Beschreibung

Study Subject Participation Status | Exception Observational Study

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1518527
received any investigation product within 30 days prior to participation in this clinical trial
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
previously enrolled in this clinical trial
Beschreibung

Study Subject Participation Status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568

Ähnliche Modelle

Eligibility Coronary Artery Disease NCT02245087

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
men 35-50 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender | Age | Female Sterilization | Postmenopausal state
Item
women 45 - 59 years of age (must be sterile or >2 years postmenopausal)
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0015787 (UMLS CUI [3])
C0232970 (UMLS CUI [4])
Serum LDL cholesterol measurement
Item
ldl cholesterol greater than 1.8 mmol/l (70 mg/dl) based on testing performed within 1 year
boolean
C0428474 (UMLS CUI [1])
Risk factor Quantity Coronary heart disease | Exception Lipid abnormality
Item
one risk factor for coronary heart disease other than lipid abnormality:
boolean
C0035648 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0010068 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0549634 (UMLS CUI [2,2])
Hypertensive disease | Systolic Pressure
Item
hypertension [bp >140 mmhg systolic]
boolean
C0020538 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
Family history Myocardial Infarction Early
Item
family history of premature myocardial infarction [<60 years]
boolean
C0241889 (UMLS CUI [1,1])
C0027051 (UMLS CUI [1,2])
C1279919 (UMLS CUI [1,3])
South Asian
Item
south asian ethnic history
boolean
C1519427 (UMLS CUI [1])
Tobacco use
Item
currently smoking
boolean
C0543414 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Anticholesteremic Agents
Item
currently taking cholesterol lowering medication
boolean
C0003277 (UMLS CUI [1])
Qualification Anticholesteremic Agents
Item
qualify for cholesterol lowering medication based on current guidelines
boolean
C1709790 (UMLS CUI [1,1])
C0003277 (UMLS CUI [1,2])
Renal dysfunction | Creatinine clearance measurement
Item
significant renal dysfunction (creatinine clearance <30 ml/min)
boolean
C3279454 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Liver Dysfunction | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
significant hepatic dysfunction (ast/alt >2.0 times upper limit of normal)
boolean
C0086565 (UMLS CUI [1])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
Malignant Neoplasms
Item
active malignancy
boolean
C0006826 (UMLS CUI [1])
Diabetes Mellitus
Item
diabetes
boolean
C0011849 (UMLS CUI [1])
Progressive Disease | Terminal illness | Condition Survival aspects Completion of clinical trial Unlikely
Item
progressive or terminal illness, or other condition in which subject is unlikely to survive the study period
boolean
C1335499 (UMLS CUI [1])
C0679247 (UMLS CUI [2])
C0348080 (UMLS CUI [3,1])
C0220921 (UMLS CUI [3,2])
C2732579 (UMLS CUI [3,3])
C0750558 (UMLS CUI [3,4])
Statin allergy | Anaphylaxis Statins | Adverse reactions Statins
Item
known allergy, hypersensitivity (anaphylaxis) ar adverse reaction to any statin
boolean
C0571873 (UMLS CUI [1])
C0002792 (UMLS CUI [2,1])
C0360714 (UMLS CUI [2,2])
C0559546 (UMLS CUI [3,1])
C0360714 (UMLS CUI [3,2])
Study Subject Participation Status | Exception Observational Study
Item
participation in a clinical trial (except observational studies) within previous 30 days
boolean
C2348568 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1518527 (UMLS CUI [2,2])
Investigational New Drugs
Item
received any investigation product within 30 days prior to participation in this clinical trial
boolean
C0013230 (UMLS CUI [1])
Study Subject Participation Status
Item
previously enrolled in this clinical trial
boolean
C2348568 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video